Discover how an ER-to-OR pathway can effectively reduce inpatient admissions and lower treatment costs, particularly during times of healthcare system stress, in this detailed study analysis.

The evolving use of dopamine D2-receptor antagonists, marked by safety concerns and an FDA black box warning on droperidol, has seen a resurgence with the FDA-approved amisulpride, highlighting the need for further research to explore its comparison with other antiemetics and its role in multimodal PONV management.

Stay abreast with the latest ACP guidelines on the management of acute left-sided colonic diverticulitis that stress a less-aggressive approach to handling uncomplicated cases, revealing a paradigm shift in diverticulitis management.

Despite striking parallels in symptomatology between POTS and autoimmune disorders, a deeper scrutiny reveals that this overlap may not be sufficient to definitively attribute an autoimmune cause to POTS; hence, indiscriminate application of immunosuppressive therapies should be re-evaluated.

A 77-year-old man with a history of solar keratoses presents a progressively enlarging and darkening lesion on his right cheek, as observed by his wife over a year, with a dermoscopic examination revealing asymmetric pigmented follicular openings and greyish globules and dots.

FDA’s approval of Opill, the first over-the-counter daily oral contraceptive, marks a major shift in contraceptive accessibility, opening new pathways in the prevention of unintended pregnancies.